AI can make drug-testing more precise, relevant to human biology
FDA proposes draft guidelines on AI use in drug development, addressing challenges and opportunities for improving safety and ...
Scientific American1d
Animal-to-Human Organ Transplants Hit Long-Awaited Testing Milestone
Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...
Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EXG-34217 for Treatment of Telomere Biology Disorders
Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of rare diseases and aging-associated diseases using its ZSCAN4 technology and mRNA platform ...
pancan2d
Continuing the Conversation: Pancreatic Cancer Clinical Trials
Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...
Vancouver biotech plans clinical trial of AI-developed drug
The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...